NCC MEDICAL GROUP is an internationally recognized developer and manufacturer of advanced neurodiagnostic and neuromonitoring technologies. Since its establishment in 1997, the company has focused on delivering high-quality solutions that support neurological diagnosis, intraoperative monitoring, and clinical neurophysiology research. Through decades of innovation and global collaboration, NCC MEDICAL GROUP has grown into a trusted partner for hospitals, research institutions, and medical distributors around the world.
As a nationally recognized SRDI “Little Giant” enterprise, NCC represents a new generation of specialized technology companies in the medical device sector. The SRDI designation—standing for Specialized, Refined, Differential, and Innovational—is awarded to organizations that demonstrate strong technical expertise, proprietary intellectual property, and continuous innovation in critical industries. This recognition reflects NCC’s commitment to developing cutting-edge neurophysiology technologies that improve patient safety and diagnostic accuracy.
The company’s research and manufacturing headquarters are located in Shanghai, one of the most advanced biomedical innovation centers in Asia. Here, multidisciplinary engineering teams work on the development of EEG systems, intraoperative neuromonitoring equipment, EMG devices, and related medical consumables. By integrating neuroscience, electronics engineering, material science, and clinical expertise, NCC continuously develops new solutions that enhance the performance and reliability of neurodiagnostic systems.
Quality management and global regulatory compliance are coordinated through NCC’s international operations center in Singapore. This strategic location allows the company to maintain strict quality standards while supporting global distribution and regulatory alignment. Every product developed by NCC undergoes rigorous testing and validation to ensure compliance with international medical device standards and clinical requirements.
NCC’s product portfolio includes a comprehensive range of neurophysiology technologies, including EEG/PSG systems, intraoperative neuromonitoring platforms, electromyography equipment, and a wide range of medical consumables such as electrodes, sensors, and accessories. These products are designed to provide reliable data acquisition, precise signal analysis, and seamless integration into hospital information systems.
Today, NCC solutions are used in more than 50 countries and in over 5,000 hospitals across China alone. The company serves a diverse range of healthcare institutions, from leading academic hospitals to regional medical centers and specialized neurological clinics. Its growing international network spans Southeast Asia, Europe, Australia, the Americas, and Africa, supported by strategic distributors and clinical partners.
Beyond product manufacturing, NCC places strong emphasis on clinical education and professional support. The company operates 31 training and technical support centers across China, providing hands-on training programs for clinicians, biomedical engineers, and technical specialists. Through the NCC Innovation Academy and the NeuGuard Service Platform, healthcare professionals gain access to ongoing education, technical guidance, and collaborative research opportunities.
By combining technological innovation, global collaboration, and comprehensive clinical support, NCC MEDICAL GROUP continues to advance its mission: Safeguarding Life and Health. Through safer surgeries, more precise neurological diagnostics, and improved patient monitoring technologies, NCC aims to contribute to the future of modern healthcare.
Copyright © NCC Medical Co., Ltd. - Privacy policy